Industry Focus

Healthcare: One Biotech Plays Red Light Green Light With the FDA

Informações:

Sinopsis

What you should know about Juno Therapeutics' recent cancer trial stop and restart. Also, we help you prep for biopharma's second quarter earnings deluge.